Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

Estimated Value: $2,000,000
Open 551 days left Healthcaregrant
Oct 28, 2024
Jan 7, 2028 12:00 AM
Healthcare
grant
AI Summary
This grant opportunity (PAR-25-024) from NIH seeks applications for the development of biomarkers or composite biomarkers for neurological and neuromuscular disorders. It utilizes an R61/R33 phased award mechanism and allows for optional clinical trials.
Line Items
ItemQtyUnitEst. Unit PriceEst. TotalCategory
Biomarker Development Services for Neurological Disorders 1 lot $500,000.00 $500,000.00 Medical
Biomarker Development Services for Neuromuscular Disorders 1 lot $500,000.00 $500,000.00 Medical
Clinical Trial Services (Optional) for Biomarker Validation 1 lot $1,000,000.00 $1,000,000.00 Medical
Estimated Bid Value$2,000,000.00

Want the full details?

Sign up free to see the agency name, contact info, and the original bid posting link.

Sign Up Free →

Related Bids

Browse More Bids

Healthcare BidsGRANT BidsClosing Soon All Bids